Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:GUD NYSE:RIV BATS:WEED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUDKnight TherapeuticsC$5.71-0.7%C$6.23C$5.09▼C$6.55C$569.02M0.05154363,299 shs31,476 shsRIVRiverNorth Opportunities Fund$11.77+0.1%$12.21$10.11▼$12.85N/AN/A94,813 shs36,668 shsWEEDRoundhill Cannabis ETF$21.46+68.9%$20.60$8.79▼$34.14$4.41M0.9811,702 shs4,713 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUDKnight Therapeutics-0.35%-1.71%-9.31%-5.12%+0.17%RIVRiverNorth Opportunities Fund+0.85%-0.67%-2.46%-1.90%-7.83%WEEDRoundhill Cannabis ETF-0.38%-5.87%+20.70%+100.40%-25.87%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUDKnight TherapeuticsC$5.71-0.7%C$6.23C$5.09▼C$6.55C$569.02M0.05154363,299 shs31,476 shsRIVRiverNorth Opportunities Fund$11.77+0.1%$12.21$10.11▼$12.85N/AN/A94,813 shs36,668 shsWEEDRoundhill Cannabis ETF$21.46+68.9%$20.60$8.79▼$34.14$4.41M0.9811,702 shs4,713 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUDKnight Therapeutics-0.35%-1.71%-9.31%-5.12%+0.17%RIVRiverNorth Opportunities Fund+0.85%-0.67%-2.46%-1.90%-7.83%WEEDRoundhill Cannabis ETF-0.38%-5.87%+20.70%+100.40%-25.87%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGUDKnight Therapeutics 3.33BuyC$7.1525.22% UpsideRIVRiverNorth Opportunities Fund 0.00N/AN/AN/AWEEDRoundhill Cannabis ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGUDKnight TherapeuticsC$384.56M1.48C$1.48 per share3.85C$7.65 per share0.75RIVRiverNorth Opportunities Fund$36.29MN/AN/AN/AN/AN/AWEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGUDKnight Therapeutics-C$30.73MN/AN/A∞N/A-8.81%-4.04%0.51%N/ARIVRiverNorth Opportunities FundN/AN/A0.00∞N/AN/AN/AN/AN/AWEEDRoundhill Cannabis ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGUDKnight TherapeuticsN/AN/AN/AN/AN/ARIVRiverNorth Opportunities Fund$1.5313.00%N/AN/AN/AWEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/ALatest RIV, WEED, and GUD DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127712.83%12/15/202512/15/202512/31/202510/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127712.83%11/14/202511/14/202511/28/202510/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127713.04%10/15/202510/15/202510/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGUDKnight Therapeutics7.523.361.79RIVRiverNorth Opportunities FundN/AN/AN/AWEEDRoundhill Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGUDKnight Therapeutics17.89%RIVRiverNorth Opportunities FundN/AWEEDRoundhill Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipGUDKnight Therapeutics45.62%RIVRiverNorth Opportunities FundN/AWEEDRoundhill Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGUDKnight Therapeutics72599.65 millionN/ANot OptionableRIVRiverNorth Opportunities FundN/AN/AN/ANot OptionableWEEDRoundhill Cannabis ETFN/A375,000N/ANot OptionableRIV, WEED, and GUD HeadlinesRecent News About These CompaniesCannabis Stocks Rally After Trump's Post On Health Benefits. But There's This Risk.September 29, 2025 | msn.comCannabis stocks surge after Trump endorses cannabidiol for senior healthcareSeptember 29, 2025 | msn.comCannabis Stocks Jump After Trump Posts CBD Promotional VideoSeptember 29, 2025 | msn.comTop-Performing ETF Areas of Q3September 26, 2025 | zacks.com5 Best-Performing Sector ETFs of AugustSeptember 3, 2025 | zacks.comTop-Performing ETF Areas of August That Are Up At Least 20%September 1, 2025 | zacks.comDisruptive Theme of the Week: Cannabis Staging a ComebackAugust 19, 2025 | etftrends.comECannabis ETFs Soar as Trump Mulls Over Marijuana ReclassificationAugust 12, 2025 | zacks.comDownbeaten cannabis stocks rally on report that Trump may lower pot's classification to a less-dangerous levelAugust 11, 2025 | marketwatch.com3 ETF Categories That Shined in July 2025August 7, 2025 | etftrends.comEBest-Performing ETF Areas of Last WeekJuly 15, 2025 | zacks.comTop & Flop ETFs of the First Half of 2025June 30, 2025 | zacks.com7 Best Marijuana Stocks and ETFs to Buy in 2025May 12, 2025 | money.usnews.com6 Best-Performing ETFs of Last WeekApril 21, 2025 | zacks.comRoundhill COIN WeeklyPay ETF (COIW)April 3, 2025 | uk.investing.comBest & Worst ETF Zones of Q1March 31, 2025 | zacks.comWhen (WEED) Moves Investors should ListenJanuary 19, 2025 | news.stocktradersdaily.comN(WEED) Pivots Trading Plans and Risk ControlsJanuary 9, 2025 | news.stocktradersdaily.comNTop & Flop ETFs of 2024December 31, 2024 | zacks.com(WEED) Long Term Investment AnalysisDecember 19, 2024 | news.stocktradersdaily.comNNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesDowngraded But Not Done: 3 Stocks Ready for a Market ComebackBy Thomas Hughes | September 24, 2025Carmax: Now is the Time to Load Up On This Used Car StockBy Thomas Hughes | September 26, 2025PayPal Stock: Why Wall Street May Be Undervaluing This GiantBy Gabriel Osorio-Mazilli | September 30, 2025Joby's Stock Is Quiet, But Its Commercial Engine Is In OverdriveBy Jeffrey Neal Johnson | September 19, 2025Azure Leads While AI Excitement Fuels Microsoft StockBy Chris Markoch | September 19, 2025RIV, WEED, and GUD Company DescriptionsKnight Therapeutics TSE:GUDC$5.71 -0.04 (-0.70%) As of 11:54 AM EasternKnight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.RiverNorth Opportunities Fund NYSE:RIV$11.76 +0.02 (+0.13%) As of 12:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.RiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.Roundhill Cannabis ETF BATS:WEED$21.46 +8.75 (+68.89%) As of 12:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Healthcare Companies Insiders Are Buying NVIDIA Analysts Lift Targets: What It Means for the Stock Price Fastenal Stock Pulls Back in October—Is It Time to Buy FAST? 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise Why Congress Is Buying Intuitive Surgical Ahead of Earnings D-Wave: Reevaluating the Short Seller’s Case After the Downgrade 3 Dividend Hikes That Signal Renewed Strength in 2025 2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
